Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. (Q44655068)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tamas Szakmany

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Anne-Catherine Raby

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Benjamin Holst

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Emmanuel Le Bouder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Constantino Diaz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Laurence Conraux

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Jean-Claude Guillemot

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Barbara Coles

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Ann Kift-Morgan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Chantal S Colmont

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Pascual Ferrara

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Judith E Hall

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Nicholas Topley

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Mario O Labéta

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

1 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

Science Translational Medicine

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

185ra64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23677593%20AND%20SRC:MED&resulttype=core&format=json

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Negative regulation of toll-like receptor-mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Immunologic alterations and the pathogenesis of organ failure in the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Anti-inflammatory mechanisms of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

21 January 2018

TLR based therapeutics

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

CD14 is a coreceptor of Toll-like receptors 7 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Soluble CD14 participates in the response of cells to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Structure and function of Toll receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

What is the pathophysiology of the septic host upon admission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

The late phase of sepsis is characterized by an increased microbiological burden and death rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Regulation of TH17 cell differentiation by innate immune signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Toll-like receptor agonists in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

The sepsis seesaw: tilting toward immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005544